Solasta Ventures

Boston, United States
CVC
Active
Total investments

29

Average round size

49M

Portfolio companies

26

Rounds per year

9.67

Lead investments

1

Follow on index

0.10

Exits

6

Stages of investment
Early Stage Venture
Areas of investment
BiotechnologySoftwareHealth CareHealth DiagnosticsEnterprise SoftwareMedicalLife SciencePharmaceuticalTherapeuticsBiopharma

Investor highlights

Industry focus
Medtech
Geo focus
South Korea

Discover reliable insights

Find relevant VC investors, identify key contacts and secure funding opportunities.

Investments analytics

Analytics

Total investments
29
Lead investments
1
Exits
6
Rounds per year
9.67
Follow on index
0.10
Investments by industry
  • Biotechnology (21)
  • Health Care (19)
  • Therapeutics (16)
  • Medical (8)
  • Life Science (7)
  • Show 31 more
Investments by region
  • United States (27)
  • New Zealand (1)
  • Canada (1)
Peak activity year
2020

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
7
Group Appearance index
0.79

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company nameDeal dateIndustryDeal stageDeal sizeLocation
01 Jan 2018Energy Efficiency, Consumer ApplicationsPre-Seed0Canada, Old Toronto
Paper.id09 Dec 2022Software, FinTech, Payments, Mobile AppsEarly Stage Venture12MJakarta Raya, Dki Jakarta, Indonesia
ReCode Therapeutics19 Sep 2023Biotechnology, Health Care, Wellness, Pharmaceutical, BiopharmaEarly Stage Venture50MUnited States, Texas, Dallas
Rescale23 Nov 2021Software, Analytics, Artificial Intelligence, Machine Learning, Enterprise Software, Software Engineering, SimulationLate Stage Venture55MUnited States, California, San Francisco

Similar funds

By same location

By same geo focus

By doing lead investments

How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.